TY - JOUR
T1 - Erratum
T2 - Prevalence of transthyretin amyloid cardiomyopathy in heart failure with preserved ejection fraction (JAMA Cardiol (2021) DOI: 10.1001/jamacardio.2021.3070)
AU - AbouEzzeddine, O. F.
AU - Davies, D. R.
AU - Scott, C. G.
N1 - Publisher Copyright:
© 2021 American Medical Association. All rights reserved.
PY - 2021/12
Y1 - 2021/12
N2 - Errors in Key Points, Abstract, Results, and Figures: In the article titled "Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction," published online August 25, 2021, in JAMA Cardiology, 1 the numbers for men andwomenwere given incorrectly in the Key Points, Abstract, text, and Figure 1. In addition, values in the Figure 2 graphswere displayed incorrectly. The article has been corrected.
AB - Errors in Key Points, Abstract, Results, and Figures: In the article titled "Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction," published online August 25, 2021, in JAMA Cardiology, 1 the numbers for men andwomenwere given incorrectly in the Key Points, Abstract, text, and Figure 1. In addition, values in the Figure 2 graphswere displayed incorrectly. The article has been corrected.
UR - http://www.scopus.com/inward/record.url?scp=85117747530&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85117747530&partnerID=8YFLogxK
U2 - 10.1001/jamacardio.2021.4325
DO - 10.1001/jamacardio.2021.4325
M3 - Comment/debate
C2 - 34613332
AN - SCOPUS:85117747530
SN - 2380-6583
VL - 6
SP - 1469
JO - JAMA cardiology
JF - JAMA cardiology
IS - 12
ER -